retatrutide what is it clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide, an investigational triple hormone

Boehringer Ingelheim Recent Developments In April 2026 , Eli Lilly's Foundayo (orforglipron) received FDA approval for adults with obesity or overweight-related health issues

The effect of liraglutide was strikingly comparable to that achieved by a well-established antipsychotic medication, haloperidol (Dixit et al., 2013)

Existing weight loss medications like Tirzepatide, offered by Polypeptide.ltd, have provided some relief, but the need for more effective options persists

And whats interesting is that you had mentioned some of the indications for the incretin agonist

The Phase 2 trial tested four active doses, and each showed distinct outcomes

GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder